Neurogene Shares Key Information on Gene Therapy Clinical Trial
Dear GP2C and Rett University Community, some important news from our friends at the Rett...
Read More
Category: Research
Acadia Announces Daybue (Trofinetide) is Now Available Commercially
Dear GP2C and Rett University Community – Great news! Acadia’s DAYBUE (Trofinetide) is now...
Read More
Acadia Announces U.S. FDA Approval of Treatment of Rett Syndrome
Girl Power 2 Cure and Rett University are excited to share the news! The first ever targeted...
Read More
Neurogene Announces New Rett Syndrome Drug Application Accepted by FDA
TODAY IS A BIG DAY! YOUR RESEARCH CONTRIBUTIONS ARE HARD AT WORK! We at Girl Power 2 Cure...
Read More
Acadia Pharmaceuticals Announces New Rett Syndrome Drug Application Accepted by FDA
Dear GP2C Community, Encouraging news from the Rett Syndrome research world! Many of our GP2C...
Read More
BIG NEWS – Taysha Gene Therapy for Rett Syndrome – Clinical Trials
There’s big news associated with an announcement from Taysha Gene Therapies. Please see the...
Read More
Research Review – February 2022
Dear GP2C & Rett University Communities, Keeping you informed! Here are some recent articles...
Read More
Acadia Pharmaceuticals Announces Positive Top-line Results
Dear GP2C Community, Here is a significant announcement about pharma test results that is...
Read More
Rett Community News
Rett University: New Course!
July Raffle
Yes/No Communication Board
2019 Great Nonprofits Top Rated Nonprofit
div.gnp_trb { visibility:hidden; }
2020 Guidestar Gold Seal of Transparency
Rett Syndrome Angels
Rettland Foundation
